ArticleFood science and biotechnology2025
Citric acid-modified starch nanoparticles for saturated fatty acid encapsulation: role of hydrophobicity.
Article in Food science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Insights into factors governing encapsulation and release performance of starch-based nanocarriers for nutraceuticals delivery.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To assess the influence of guest compound hydrophobicity on encapsulation using citric acid-modified starch nanoparticles (mSNPs), saturated fatty acids with varying chain lengths (C:4-18) were subjected to nanoprecipitation using mSNPs at concentrations of 1, 3, and 5%. The interactions between fatty acids and mSNPs were characterized through transmission electron microscopy and Fourier-transform infrared spectroscopy, revealing the formation of spherical aggregates facilitated by hydrogen bonding and hydrophobic interactions. Higher mSNP content and fatty acids with longer chains resulted in larger composite sizes. Additionally, with an increase in the fatty acid chain length, the amount of bound fatty acids in the composites decreased, while the absolute zeta potential and hydrophobicity of the composites increased. In simulated intestinal fluid, the release of fatty acids from the composites exhibited a gradual pattern, with a delayed release rate observed for fatty acids with longer chain lengths. Supplementary Information: The online version contains supplementary material available at 10.1007/s10068-025-01989-7.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.